Filing Details
- Accession Number:
- 0001062993-13-005972
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-20 16:02:23
- Reporting Period:
- 2013-11-18
- Filing Date:
- 2013-11-20
- Accepted Time:
- 2013-11-20 16:02:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875622 | Biospecifics Technologies Corp | BSTC | Pharmaceutical Preparations (2834) | 113054851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1375378 | Paul Gitman | 167 Executive Drive Manhasset Hills NY 11040 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Disposition | 2013-11-18 | 7,000 | $22.00 | 59,425 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2013.
Billionaire Hedge Funds
